Skip to main content
. 2023 Feb 27;15(4):e17450. doi: 10.15252/emmm.202317450

Figure EV2. Lipid metabolism features of POI.

Figure EV2

  • A
    Heatmap showing the top 25 differentially abundant metabolites in the ovaries of mice on a low BCAA diet. Control, N = 10; low BCAA, N = 8.
  • B
    The relative abundance of BCAAs in the ovaries of mice on a low BCAA diet. Control, N = 10; low BCAA, N = 8; Boxplot, central band stands for median, boxes stand for 50% of the data, and whiskers stand for min or max of the data.
  • C
    GSEA of the proteomics data in the serum of the Fudan Cohort. N = 11.
  • D
    GSEA of RNA‐seq data from the liver in the mice on a low BCAA diet or control diet. N = 6.
  • E
    The PCA of serum from mice on a low BCAA diet or control diet. N = 10.
  • F
    The relative cell viability of KGN cells with ceramide treatment. N = 6.
  • G
    The percentage of Annexin V positive cells of KGN cells with ceramide treatment. N = 3.
  • H–J
    The pregnancy rate, body weight, and food intake from mice with ceramide treatment. N = 10.
  • K
    The relative abundance of ceramide in the serum of mice with myriocin treatment. N = 3; Truncated violin plot, central band stands for median, and dotted lines stand for the upper quartile or the lower quartile of the data.
  • L
    The serum concentration of FSH in mice with ceramide treatment. N = 8.
  • M
    The changes in follicle count from mice with ceramide treatment. N = 8.

Data information: S1, Primordial; S2, Primary; S3, Secondary; S4, Antral; S5, Atretic. Error bars stand for SEM. The P‐value was calculated by a two‐tailed t‐test with 2‐way ANOVA correction.

Source data are available online for this figure.